GENWORTH FINANCIAL INC
GNWNYSEFinancials · Life Insurance · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $7.30B | $7.29B | $7.49B | $7.50B | $7.82B | $8.28B |
| Operating income | — | — | $41.0M | $818.0M | $474.0M | $310.0M |
| Net income | $223.0M | $299.0M | $76.0M | $916.0M | $850.0M | $178.0M |
| Total assets | $88.08B | $86.82B | $90.82B | $89.71B | $122.35B | $105.75B |
| Total liabilities | $78.32B | $77.44B | $82.48B | $81.33B | $120.27B | $89.93B |
| Equity | $8.75B | $8.44B | $7.48B | $7.63B | $1.57B | $15.32B |
| EPS (diluted) | $0.54 | $0.68 | $0.16 | $1.79 | $1.65 | $0.35 |
| Shares out. | 418.9M | 442.6M | 493.3M | 507.4M | 505.8M | 504.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 3.1%
- Return on equity
- 2.5%
- Return on assets
- 0.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 88.9%
- Debt / equity
- 8.95×
- Book value / share
- $20.89
- Revenue growth (YoY)
- 0.1%
- Net income growth (YoY)
- −25.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −0.1%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- High leverage (liabilities > 70% of assets)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Mcinerney Thomas JOfficer — President and CEO; Director | May 27, 2026 | Gift | 200,000 | $0.00 |
| Mcinerney Thomas JOfficer — President and CEO; Director | May 22, 2026 | Sell | 100,000 | $9.27 |
| Restrepo Robert P JrDirector | May 22, 2026 | Sell | 50,000 | $9.12 |
| Taylor Morris C.Officer — EVP & CIO | May 21, 2026 | Option exercise | 21,521 | — |
| Van Wyk Steven C.Director | May 20, 2026 | Grant | 32,100 | $9.03 |
| Smith Ramsey D.Director | May 20, 2026 | Grant | 18,264 | $9.03 |
| Sarsynski Elaine ADirector | May 20, 2026 | Grant | 32,100 | $9.03 |
| Restrepo Robert P JrDirector | May 20, 2026 | Grant | 18,264 | $9.03 |
| Mills Howard D. IiiDirector | May 20, 2026 | Grant | 18,264 | $9.03 |
| Higgins Melina EDirector | May 20, 2026 | Grant | 31,547 | $9.03 |
| Goodman Jill RDirector | May 20, 2026 | Grant | 18,264 | $9.03 |
| Dyson Karen ElizabethDirector | May 20, 2026 | Grant | 18,264 | $9.03 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 6.7M | 2.6 | -7.2% |
| Apr 30, 2026 | 7.2M | 2.9 | -1.5% |
| Apr 15, 2026 | 7.3M | 2.3 | +9.7% |
| Mar 31, 2026 | 6.7M | 1.9 | -13.4% |
| Mar 13, 2026 | 7.7M | 2.0 | +0.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 21, 2026
- Results of operationsMay 5, 2026
- Results of operationsFeb 23, 2026
- Results of operationsFeb 3, 2026
- Results of operationsNov 5, 2025
- Results of operationsJul 30, 2025
- Item 5.04Jul 18, 2025
- Shareholder voteMay 22, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.